Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Aroplatin and Capecitabine in Subjects With Unresectable Local Recurrence or Distant Metastases of Colorectal Cancer Refractory to 5-FU/Leucovorin and Irinotecan

NCT00081536 is registered in ClinicalTrials.gov with Aronex Pharmaceuticals as lead sponsor.

NCT NCT00081536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00081536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Aroplatin and Capecitabine in Subjects With Unresectable Local Recurrence or Distant Metastases of Colorectal Cancer Refractory to 5-FU/Leucovorin and Irinotecan
Lead sponsor
Aronex Pharmaceuticals
Phase
Phase 1/2
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
105
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms